FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

DRI Ecstasy Plus Assay

K Number: K240670 · Decision Oct 30, 2024
Classifications
1
FEI Numbers
96
Registration Numbers
96
Same Product Code
224
Applicant Total
21
Review Days
233

Research this 510(k) in seconds

The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
DRI Ecstasy Plus Assay
K Number
K240670
Device Class
FDA class 2
Clearance Type
Special
Regulation Number
862.3100
Medical Specialty
Clinical Toxicology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
Microgenics Corporation
Date Received
March 11, 2024
Decision Date
October 30, 2024
Product Code
DKZ
Advisory Committee
Clinical Toxicology
Review Advisory Committee
TX
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
DKZ Enzyme Immunoassay, Amphetamine

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (DKZ), ordered by most recent decision date.

View all

Other Clearances by Microgenics Corporation

K Number Device Name
K243498 Alinity c Benzodiazepines Reagent Kit
K231020 Alinity c Tricyclic Antidepressants Reagent Kit
K231007 CEDIA Heroin Metabolite (6-AM) Assay
K213875 DRI TM Tricyclics Serum Tox Assay
K211973 DRI Cocaine Metabolite Assay
K192943 CEDIA Heroin Metabolite (6-AM) assay
K190968 CEDIA Benzodiazepine Assay
DEN180030 QMS Plazomicin Immunoassay
K181499 DRI Cocaine Metabolite Assay
K173963 DRI Benzodiazepine Assay
Search all 21 clearances from Microgenics Corporation →